- Atlanta-based hemp company Verde Leaf has appointed Priscilla Agoncillo to its Board of Directors.
- Agoncillo will be serving as president and board chairwoman of Medadex Pharma, where she will oversee product development and testing.
- Agoncillo brings years of cannabis experience with her, along with a history of advocating for marijuana legalization.
Priscilla Agoncillo, president of the Cannabinoid Industry Association (CBDIA), is being appointed to Verde Leaf’s Board of Directors and will lead testing and product development for new CBD products being made by a subsidiary.
Agoncillo will serve as president and board chairwoman of Medadex Pharma. She will also continue to serve as president for the board of advisors of CBDIA.
“One important objective for any CBD company is to validate their products: their safety, efficacy and consistency. R&D is critical to achieve this validation. I am excited to align the goals of Verde Leaf™ with the right companies & projects in the space who share the same mission in delivering quality products consumers can trust through proper research,” stated Agoncillo.
Agoncillo will be responsible for overseeing product development and efficacy testing for Medadex Pharma and plans to develop CBD treatments that are approved by the U.S. Food and Drug Administration (FDA). She has years of experience as a cannabis entrepreneur and activist in the state of California and even served as a campaign field director during the 2010 campaign to legalize recreational marijuana that fell short of a passing vote.
President and CEO of Verde Leaf, Jackson Garth, is excited about the addition of Agoncillo, stating in a press release:
“From the moment we connected, I recognized her knowledge, experience, and connections in the industry. We feel Ms. Agoncillo would help our company as a whole to propel into the next phase of growth, especially with her real-world experience of developing a Cannabinoid Pharmaceutical company from scratch. Her unique background in owning a licensed Cannabinoid farm and her experience in sector from seed-to-sale is a full-spectrum perspective that will help us define and enhance our competitive edge in the marketplace. We are excited and honored to have her become a part of our executive leadership team. Expect some great things ahead from Verde Leaf™ and Medadex Pharma.”